Adam Hamm

Adam Hamm serves as Sr. Vice President, Biostatistics and Strategic Consulting and has over 17 years of experience in clinical trials research. Prior to joining SDC, Adam served as the Head of North America Biostatistics at Cytel and has held other leadership positions at various CRO’s. Adam’s clinical trial experience spans a variety of therapeutic areas and includes successful submissions leading to regulatory approvals for therapeutics in central nervous system disorders and respiratory disease. Adam has technical expertise in adaptive designs and statistical software platforms that utilize clinical trial simulations for efficient and statistically rigorous designs for innovative trials, including early phase oncology trials. For over fifteen years, Adam has had successful and collaborative interactions with regulatory agencies, communicating and consulting on various regulatory and statistical issues on behalf of clients over many therapeutic areas. Adam holds a BS in Mathematics from Virginia Tech and a Ph.D. in Biostatistics from Virginia Commonwealth University (Medical College of Virginia Campus).